☆Kalehua Capital Management LLC
Quality Q
0.222
AUM ($M)
174
Positions
26
Turnover
0.26
Top-10 wt
71%
Herfindahl
0.069
History (qtrs)
3
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 30 positions · portfolio value $140M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆MANE funds › | Veradermics Inc | ADD | — | 12.8% | +7.4% | 17.9 | 145,695 | +42,816 | 2 | — |
| ☆XFOR funds › | X4 Pharmaceuticals Inc | HOLD | — | 12.5% | -0.5% | 17.4 | 3,722,840 | +0 | 2 | — |
| ☆CMPS funds › | Compass Pathways Plc | HOLD | — | 8.3% | +4.5% | 11.6 | 819,692 | +0 | 2 | — |
| ☆SRZN funds › | Surrozen Inc | HOLD | — | 7.2% | -2.3% | 10.0 | 385,178 | +0 | 2 | — |
| ☆ACRS funds › | Aclaris Therapeutics Inc | ADD | — | 6.9% | +2.7% | 9.7 | 1,832,365 | +494,809 | 2 | — |
| ☆SION funds › | Sionna Therapeutics Inc | HOLD | — | 6.2% | -0.4% | 8.7 | 197,072 | +0 | 2 | — |
| ☆IKT funds › | Inhibikase Therapeutics Inc | ADD | — | 5.6% | +1.8% | 7.8 | 3,821,890 | +1,149,282 | 2 | — |
| ☆PHVS funds › | Pharvaris NV | HOLD | — | 4.9% | +0.2% | 6.9 | 198,772 | +0 | 2 | — |
| ☆KPTI funds › | Karyopharm Therapeutics Inc | NEW | — | 4.8% | +4.8% | 6.7 | 685,644 | +685,644 | 1 | — |
| ☆SEPN funds › | Septerna Inc | HOLD | — | 4.7% | +0.7% | 6.5 | 194,544 | +0 | 2 | — |
| ☆IFRX funds › | Inflarx Nv | NEW | — | 4.7% | +4.7% | 6.5 | 2,897,769 | +2,897,769 | 1 | — |
| ☆CYCN funds › | Cyclerion Therapeutics Inc | NEW | — | 4.0% | +4.0% | 5.6 | 1,651,350 | +1,651,350 | 1 | — |
| ☆QURE funds › | Uniqure Nv | TRIM | — | 2.6% | -0.3% | 3.7 | 79,407 | -132,295 | 2 | — |
| ☆LONA funds › | LeonaBio Inc | HOLD | — | 2.6% | -0.8% | 3.6 | 393,701 | +0 | 2 | — |
| ☆DMRA funds › | Damora Therapeutics Inc | HOLD | — | 2.6% | -0.4% | 3.6 | 139,000 | +0 | 2 | — |
| ☆MLTX funds › | MoonLake Immunotherapeutics | HOLD | — | 2.5% | -0.3% | 3.4 | 175,734 | +0 | 2 | — |
| ☆TYRA funds › | Tyra Biosciences Inc | HOLD | — | 1.7% | -0.7% | 2.4 | 74,465 | +0 | 2 | — |
| ☆NVCT funds › | Nuvectis Pharma Inc | NEW | — | 1.3% | +1.3% | 1.8 | 100,000 | +100,000 | 1 | — |
| ☆GOSS funds › | Gossamer Bio Inc | ADD | — | 1.3% | -0.8% | 1.8 | 11,149,363 | +3,677,523 | 2 | — |
| ☆MIST funds › | Milestone Pharmaceuticals Inc | NEW | — | 1.2% | +1.2% | 1.7 | 1,269,237 | +1,269,237 | 1 | — |
| ☆ATYR funds › | Atyr Pharma Inc | NEW | — | 0.8% | +0.8% | 1.1 | 1,788,167 | +1,788,167 | 1 | — |
| ☆TIL funds › | Instil Bio Inc | TRIM | — | 0.5% | -0.4% | 0.8 | 99,600 | -40,249 | 2 | — |
| ☆TCRX funds › | Tscan Therapeutics Inc | NEW | — | 0.3% | +0.3% | 0.4 | 454,876 | +454,876 | 1 | — |
| ☆KLRS funds › | Kalaris Therapeutics Inc | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -135,585 | 0 | — |
| ☆RLAY funds › | Relay Therapeutics Inc | EXIT | — | 0.0% | -7.6% | 0.0 | 0 | -901,457 | 0 | — |
| ☆ORKA funds › | Oruka Therapeutics Inc | EXIT | — | 0.0% | -4.9% | 0.0 | 0 | -118,524 | 0 | — |
| ☆PEPG funds › | PepGen Inc | EXIT | — | 0.0% | -1.1% | 0.0 | 0 | -729,961 | 0 | — |
| ☆DMAC funds › | DiaMedica Therapeutics Inc | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -62,488 | 0 | — |
| ☆TNYA funds › | Tenaya Therapeutics Inc | EXIT | — | 0.0% | -1.2% | 0.0 | 0 | -2,000,000 | 0 | — |
| ☆BOXX funds › | Alpha Architect 1-3 Month Box ETF | EXIT | — | 0.0% | -11.6% | 0.0 | 0 | -118,422 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 140 | 23 | 0.34 | 74% | 0.070 | 0.120 | — | in |
| 2026Q1 | 119 | 23 | 0.30 | 72% | 0.068 | 0.146 | — | entered |
| 2025Q4 | 101 | 19 | 0.00 | 84% | 0.119 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status